Landscapes / Targets
TL1A
5 drugs act on TL1A, in 35 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs5
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Artificial immunoglobulin |
Roche · Public ROG.SW |
Phase 3 | 31 Dec 2026Phase 2 trial completes | ||
| How it works | An antibody | ||||
| Next date | 31 Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Moderately to Severely Active Ulcerative Colitis, Moderately to Severely Active Crohns Disease and 5 more | ||||
| Open drug page | |||||
Artificial immunoglobulin |
Merck & Co. · Public MRK |
Phase 3 | 17 Feb 2027Phase 2 trial completes | ||
| How it works | An antibody | ||||
| Next date | 17 Feb 2027 · Phase 2 trial completes | ||||
| Also tested for | Diffuse Cutaneous Systemic Sclerosis, Interstitial Lung Disease and 10 more | ||||
| Open drug page | |||||
Unmodified immunoglobulin |
Teva Branded Pharmaceutical Products R&D +1 |
Phase 3 | 9 May 2028Phase 3 trial completes | ||
| How it works | An antibody | ||||
| Next date | 9 May 2028 · Phase 3 trial completes | ||||
| Also tested for | Crohn's Disease, Ulcerative Colitis and 3 more | ||||
| Open drug page | |||||
— |
Phase 2 | Jan 2027Phase 2 trial completes | |||
| Next date | Jan 2027 · Phase 2 trial completes | ||||
| Also tested for | Crohn's Disease (CD), Ulcerative Colitis (UC) | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 5 of 5 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026